FRIDAY, MAY 17, 2024 (HealthDay News) — The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer. Importantly, tarlatamab (Imdelltra) is only for patients who have exhausted all other options to treat extensive-stage small cell lung cancer.Continue Reading

FRIDAY, May 17, 2024 (HealthDay News) — Cutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new study shows. Chemotherapies, immunotherapies, targeted therapies and hormone therapies do not improve survival rates in patients with very advanced tumors near the end of life, according to findings publishedContinue Reading

FRIDAY, May 17, 2024 (HealthDay News) — Men are more vulnerable than women to the debilitating effects of diabetes, a new long-term study finds. Overall rates of diabetes are similar between men and women, according to the report published May 16 in the Journal of Epidemiology & Community Health. ButContinue Reading